• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    AMERIPHARMA

    Syngene International Ltd.

    Bachem

    Quotient Sciences

    Federal Equipment Company
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    AMERIPHARMA

    Syngene International Ltd.

    Bachem

    Quotient Sciences

    Federal Equipment Company
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Advances in Intelligent Automation

    The future of medicine relies on further digital transformation and automation-enabling solutions to improve drug development and monitoring.

    Advances in Intelligent Automation
    Updesh Dosanjh, Practice Leader, Technology Solutions, IQVIA12.14.20

    The demand for more agile, efficient operations is rapidly increasing. The COVID-19 pandemic has put unprecedented pressure on the pharma industry to implement innovative technologies, such as artificial intelligence (AI), machine learning (ML) and natural language processing (NLP), on a more expedited and broad-based scale than ever before. Subsequently, the industry is shifting its perception of automation-enabling solutions with embedded intelligence from the proof-of-concept to proof-of-value stage. This provides a clearer indication of the digital advancements that the life sciences industry must take to address the changing industry landscape and demands.

    Life sciences will transform negative perceptions about AI/ML-powered decision-making. The world needs COVID-19 vaccines and treatments they trust, and soon. The life sciences industry is employing the efficiencies of artificial intelligence and machine learning (AI/ML) to reduce the time between drug discovery and market availability from years to months. These technologies are tools for both reducing tedious time-consuming data collection and enabling comparison of much larger and diverse data sets. Without these technologies, it used to take 40-plus scientists with doctorate degrees 25 years or more to discover a single marketable drug. Technological advances have sped up the modeling of 1,000 drugs to 40 minutes and for example allowing the process of Orphan drug discovery and production to be financially viable.

     

    But many industry professionals still harbor negative perceptions of these new technologies and have been slow to adopt them into other areas – comparing them to “self-driving” cars. On the contrary, life science professionals are assisted rather than replaced by AI/ML technologies. The cumbersome work of weeding through the data is circumvented to enable humans to do the hardest and most important task – making informed decisions based on reliable, relevant and timely data.

     

    The benefits of AI and ML are difficult to ignore and when designed correctly. New automation-enabling capabilities can transform how organizations collect and understand data. These technological advances will shift the way pharmaceutical professionals work, enabling them to move away from routine data entry toward more meaningful analysis and more value-adding work.

     

    Virtual/remote clinical trials with AI-enabled safety monitoring will increase clinical trial participation. Virtual and remote clinical trials are helping to keep many medical advancements up and running during the global pandemic. Remote health care visits are on the rise amidst COVID. Remote visits accounted for more than 40 percent of primary care visits for patients with traditional Medicare, increasing by 400 percent (from a tiny 0.1 percent sliver before the public health emergency at the height of the COVID-19 shutdown).

     

    COVID-19 has accelerated the need for a faster, more accessible clinical trial process. With the introduction of virtual or remote clinical trials, we’ll begin to see the concept of the continuous clinical trial evolve. This will include enhanced patient surveillance, or pharmacovigilance monitoring to ensure drug safety – even after the drug is brought to market.

     

    Pharmaceutical companies will become more data science-oriented with advanced technologies to accomplish this, including automation and artificial intelligence (AI). This will help them continuously and proactively monitor patient safety data. By incorporating these automated technologies into the virtual clinical trial process, organizations can identify adverse event indicators swiftly and efficiently, as early as possible, to ensure the utmost patient safety. 

    In a COVID world in which there is a push to make telemedicine more widely available, automation and AI technologies will serve as a key indicator and communicator throughout the clinical trial process. As further evidence of the growth here, a recent poll of older adults by the University of Michigan Institute for Healthcare Policy & Innovation found that more than 7 in 10 are interested in using telehealth for follow-ups with their doctor, and nearly 2 out of 3 feel comfortable with video conferences. In addition, the government’s flagship health care program, Medicare, has temporarily waived restrictions predating the smartphone era. Medicare covers more than 60 million people, including those age 65 and older, and younger disabled people.

    The benefits of virtual and remote trials go beyond patient safety monitoring. These more digitalized trials also enable bi-directional data sharing, reducing friction between collecting important data points and automating the assessment of a patient’s condition with these more informed and robust sets of insights.

    The future of medicine relies upon further digital transformation. In 2021 and beyond, purpose-built automation-based solutions will become critical for improving and expediting vaccine and treatment development, as well as safety and efficacy requirements for monitoring those treatments via pharmacovigilance practices. The industry’s ability to combat the current pandemic with life-saving vaccines and treatments, and help prepare for any future global health events, relies on its ability to continue to innovate (informed by new data and insights), in pursuit of true digital transformation.

     



    Updesh Dosanjh is a  Practice Leader for the Technology Solutions business unit of IQVIA. In his role, Updesh is responsible developing the overarching strategy regarding AI and Machine Learning as it relates to safety and pharmacovigilance. He has over 25 years of knowledge and experience in the management, development, implementation, and operation of processes and systems within the life sciences and other industries. Most recently, Dosanjh was with Foresight and joined IQVIA as a result of an acquisition.
    Related Searches
    • Drug Development
    • Clinical Trials
    • Information Technology
    Suggested For You
    Three Tips for Navigating Post-Approval Pharmacovigilance Three Tips for Navigating Post-Approval Pharmacovigilance
    Ensuring Equitable Access to Next-generation Sequencing in Oncology Ensuring Equitable Access to Next-generation Sequencing in Oncology
    Evotec Opens cGMP Manufacturing Facility in Redmond, WA Evotec Opens cGMP Manufacturing Facility in Redmond, WA
    Lumen Bioscience, Google Partner to Apply ML to Biologics Manufacturing Lumen Bioscience, Google Partner to Apply ML to Biologics Manufacturing
    The Real Cost of Bringing Manufacturing Home The Real Cost of Bringing Manufacturing Home
    Cognizant Agrees to Acquire TQS Integration Cognizant Agrees to Acquire TQS Integration
    CMIC and Lokavant Partner to Deploy Clinical Trial Intelligence Platform CMIC and Lokavant Partner to Deploy Clinical Trial Intelligence Platform
    Driving Efficiencies in Today’s Complex Trials Driving Efficiencies in Today’s Complex Trials
    AbCellera Breaks Ground on Global HQ in Vancouver AbCellera Breaks Ground on Global HQ in Vancouver
    Ensuring Pharma Manufacturing Quality Ensuring Pharma Manufacturing Quality
    LabVantage Solutions Expands and Improves its Portfolio LabVantage Solutions Expands and Improves its Portfolio
    What Will Change at FDA for 2021? What Will Change at FDA for 2021?
    Regulatory Practices in a Post-Pandemic World Regulatory Practices in a Post-Pandemic World
    Evozyne, Takeda Ink Strategic Protein Design Agreement Evozyne, Takeda Ink Strategic Protein Design Agreement
    Life Sciences Strive for Greater Agility Life Sciences Strive for Greater Agility

    Related Expert's Opinion

    • cGMP Manufacture | Drug Development | QA/QC
      Three Tips for Navigating Post-Approval Pharmacovigilance

      Three Tips for Navigating Post-Approval Pharmacovigilance

      Seamlessly transition from regulatory reporting to post-approval safety surveillance in today’s market.
      Emmanuel Belabe, Associate Vice President, Safety Product Management, ArisGlobal, Nina Patel Lahanis, Associate Vice President, Safety Science, EVERSANA 09.08.21

    • Bioanalytical Services
      Ensuring Equitable Access to Next-generation Sequencing in Oncology

      Ensuring Equitable Access to Next-generation Sequencing in Oncology

      Recent advances in sequencing techniques have transformed cancer treatment.
      Gang Song, Ph.D., CEO & Co-Founder, Pillar Biosciences 08.20.21

    • Biologics, Proteins, Vaccines | Breaking News
      Evotec Opens cGMP Manufacturing Facility in Redmond, WA

      Evotec Opens cGMP Manufacturing Facility in Redmond, WA

      Expands capabilities into commercial biologics manufacturing and adds late stage clinical development and commercial supply for drug substance.
      08.11.21


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Lumen Bioscience, Google Partner to Apply ML to Biologics Manufacturing

      Lumen Bioscience, Google Partner to Apply ML to Biologics Manufacturing

      Aims to double biomanufacturing productivity.
      08.11.21

    • The Real Cost of Bringing Manufacturing Home

      The Real Cost of Bringing Manufacturing Home

      Bikash Chatterjee of Pharmatech Associates discusses the reshoring trend, technologies and advances that could help deliver more manufacturing back to the U.S.
      08.04.21

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    • Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Natrol Launches First Non-Melatonin Sleep Supplement
    Metagenics Releases Consumer Survey on Menopausal Support Supplement
    Coatings World

    Latest Breaking News From Coatings World

    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    AkzoNobel Shares Sustainable Architectural Solutions at Conference
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Stoelzle Glass Group Names New CEO
    Happi

    Latest Breaking News From Happi

    The Estée Lauder Companies Launches 2023 Breast Cancer Campaign
    BASF Personal Care Introduces New Cosmetic Ingredient
    Breakfast with Oral Care Benefits?
    Ink World

    Latest Breaking News From Ink World

    Siegwerk’s Climate Targets Validated by SBTi
    ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
    Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
    SCHOTT Strengthens Glass Substrate Portfolio

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login